State of Wyoming’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Sell
4,812
-2,910
-38% -$86K 0.02% 1110
2026
Q1
$214K Sell
7,722
-1,579
-17% -$40.6K 0.03% 894
2025
Q4
$202K Sell
9,301
-2,421
-21% -$47.8K 0.02% 965
2025
Q3
$177K Sell
11,722
-2,429
-17% -$30.1K 0.02% 1035
2025
Q2
$159K Buy
+14,151
New +$153K 0.02% 1056
2023
Q3
Sell
-802
Closed -$8.08K 1785
2023
Q2
$8.08K Buy
+802
New +$7.17K ﹤0.01% 1482
2022
Q1
Sell
-3,428
Closed -$35K 1990
2021
Q4
$35K Buy
+3,428
New +$28.5K 0.02% 1271

Other funds holding ROIV

State of Wyoming's ROIV Position: Q2 2026 in Review

State of Wyoming reduced its Roivant Sciences (ROIV) stake by 38% in Q2 2026, selling an estimated $86K and leaving 4,812 shares worth $170K. The position accounts for 0.02% of the portfolio, ranked #1110.

State of Wyoming first reported a position in ROIV in Q4 2021 and has held it in 7 quarters since. The position peaked at $214K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • State of Wyoming held 4,812 shares of Roivant Sciences worth $170K as of Q2 2026.
  • State of Wyoming sold 2,910 Roivant Sciences shares in Q2 2026, an estimated $86K.
  • Roivant Sciences made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1110 holding.
  • State of Wyoming first reported a position in Roivant Sciences in Q4 2021 and has held it in 7 quarters since.
  • State of Wyoming's Roivant Sciences position peaked at $214K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.